Outlook Quality of Life Intervention Study
Cancer, Congestive Heart Failure (CHF), Chronic Obstructive Pulmonary Disease (COPD)
About this trial
This is an interventional supportive care trial for Cancer focused on measuring quality of life, end of life, self-disclosure, palliative care
Eligibility Criteria
Inclusion Criteria:
- Patients with
- Advanced cancer
- Congestive heart failure
- COPD
- End stage renal disease
Exclusion Criteria:
- Cognitive impairment
- inability to speak
- non-English speaking
Sites / Locations
- Durham VA Medical Center HSR&D COE
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
No Intervention
Outlook Intervention
Attention Control
Treatment as Usual
Subjects in the first group ("Life Completion") completed a psychosocial intervention which consisted of meeting with the facilitator three times for 45-60 minutes each. In the first session, subjects were asked to discuss issues related to life review. In session two, participants spoke about issues of regret and forgiveness. In the final session, subjects focused on heritage and legacy.
The subjects in the second group ("attention control") met with a facilitator three times for 45 minutes and listened to a non-guided relaxation CD.
Subjects in the third group ("treatment as usual") were exposed to no intervention or attention control during the intervention window.